These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 33619010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S.
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [Abstract] [Full Text] [Related]

  • 4. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA.
    Circulation; 2015 Oct 27; 132(17):1604-12. PubMed ID: 26384160
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Oct 27; 27(1):47-59. PubMed ID: 21329862
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease.
    You SC, An MH, Yoon D, Ban GY, Yang PS, Yu HT, Park RW, Joung B.
    Heart Rhythm; 2018 Dec 27; 15(12):1825-1832. PubMed ID: 30509364
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
    Koh KK, Song JH, Kwon KS, Park HB, Baik SH, Park YS, In HH, Moon TH, Park GS, Cho SK.
    Int J Cardiol; 1995 Nov 24; 52(2):167-74. PubMed ID: 8749878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rate control in atrial fibrillation: many questions still unanswered.
    Van Gelder IC, Hobbelt AH, Mulder BA, Rienstra M.
    Circulation; 2015 Oct 27; 132(17):1597-9. PubMed ID: 26384161
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L, Grimard C, Pierre B, Nonin E, Gorin L, Rauzy B, Cosnay P, Babuty D, Charbonnier B.
    Am J Cardiol; 2009 Jan 15; 103(2):248-54. PubMed ID: 19121446
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996.
    Stafford RS, Robson DC, Misra B, Ruskin J, Singer DE.
    Arch Intern Med; 1998 Oct 26; 158(19):2144-8. PubMed ID: 9801182
    [Abstract] [Full Text] [Related]

  • 20. Comparison between beta-blockers and calcium channel blockers in patients with atrial fibrillation according to renal function.
    Parada Barcia JA, Raposeiras Roubin S, Fernández DG, García AG, Otero CI, González Bermúdez I, Íñiguez Romo A, Abu-Assi E.
    Clin Cardiol; 2024 May 26; 47(5):e24257. PubMed ID: 38664980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.